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https://doi.org/10.1016/j.stemcr.2018.06.007SUMMARYSincehundreds of clinical trials are investigating the use ofmultipotent stromal cells (MSCs) for therapeutic purposes, effective delivery of
the cells to target tissues is critical. We have found an unexplored mechanism, by which basic fibroblast growth factor (FGF2) induces
expression of fucosyltransferase 8 (FUT8) to increase core fucosylations of N-linked glycans of membrane-associated proteins, including
several integrin subunits. Gain- and loss-of-function experiments show that FUT8 is both necessary and sufficient to inducemigration of
MSCs. Silencing FUT8 also affects migration of MSCs in zebrafish embryos and a murine bone fracture model. Finally, we use in silico
modeling to show that core fucosylations restrict the degrees of freedom of glycans on the integrin’s surface, hence stabilizing glycans
on a specific position. Altogether, we show a mechanism whereby FGF2 promotes migration of MSCs by modifying N-glycans. This
work may help improve delivery of MSCs in therapeutic settings.INTRODUCTION
Despite the marked safety profile and long-established
potential of multipotent stromal cells (MSCs) to promote
tissue repair, their use has been limited mostly to small
clinical trials, with only modest efficacy (Trounson and
McDonald, 2015). A major barrier to the effective applica-
tion of MSCs has been the poor ability to target these cells
to tissues of interest (Karp and Leng Teo, 2009). For
example, therapies aiming for bone repair require that in-
jected cells home to the bone marrow, a process that is
highly inefficient (Grayson et al., 2015; Rombouts and
Ploemacher, 2003).
Glycosylation is a common post-translational modifica-
tion of proteins that affects many cell functions, including
adhesion, migration, and signaling (Cummings and Pierce,
2014; Moremen et al., 2012). N-glycans are sugars attached
to Asparagine in Asn-X-Ser/Thr peptides, where X can be
any amino acid, except for proline. It has been proposed
that N-linked glycosylations (N-glycans) may affect cell
migration both positively and negatively (Gu and Tanigu-
chi, 2008), although the experimental evidence is mostly
limited to selectin binding. Of note, chemical engineering
of glycosylations promotes MSC homing to the bone
marrow (Sackstein et al., 2008), suggesting that N-glycans
could play a critical role in MSC migration.
During MSC expansion, basic fibroblast growth factor
(FGF2) is often used to increase cell proliferation (TsutsumiStem Cell Re
This is an open access article under the Cet al., 2001), maintain differentiation potential (Solchaga
et al., 2005), and delay cellular senescence (Ito et al.,
2007). It has also been shown that FGF2 promotes migra-
tion ofMSCs in vitro (Schmidt et al., 2006), although no po-
tential mechanism for FGF2-mediated migration has been
described. Therefore, we aimed to determine changes at
mRNA andN-glycan levels that could account for increased
migration of MSCs, potentially leading to new approaches
to improve MSC delivery.RESULTS
FGF2 Promotes Migration of MSCs by Altering Gene
Expression and N-Glycans
To test the effect of FGF2 onmigration of MSCs, two exper-
imental approaches were used. In the wound/scratch assay,
MSCs are seeded so that a constant gap or ‘‘wound’’ is left
in-between the monolayer of cells. Closure of the wound
over time is therefore proportional to the migration ability
of the cells. To complement this assay, we used single-cell
tracking, where the displacement of individual cells over
time (speed) is recorded using videomicroscopy. In both
in vitro assays, treatment with FGF2 significantly increased
migration of MSCs (Figures 1A, 1B, and S1).
To identify changes in gene expression that could ac-
count for increased migration, we performed deep-
sequencing transcriptome analysis (RNA-seq) on MSCsports j Vol. 11 j 325–333 j August 14, 2018 j ª 2018 The Author(s). 325
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Figure 1. FGF2 Promotes Migration by Increasing FUT8 and Core Fucosylations
(A) Wound/scratch assay, where closed area represents MSC migration after 24 hr, N = 5.
(B) Cell tracking using videomicroscopy. MSC displacement over time (speed) was recorded for 24 hr and tracked using ImageJ software. A
total of 30 cells per condition (derived from two different donors) were analyzed.
(C) RT-PCR confirming differential expression of genes related to cell migration, N = 6.
(D) Representative chromatograms of N-glycans detected by MS and semi-quantification of core-fucosylation levels, N = 5.
(E) Wound/scratch assay showing the effect of silencing FUT8 on FGF2-induced migration (N = 6).
(F) RT-PCR showing differential expression of genes associated with core fucosylations and FUT8 expression, N = 6.
(G) Western blots in MSCs transduced with the indicated lentivirus and treated with or without FGF2 (N = 3).
Error bars indicate standard error of the mean (SEM). For all statistical analyses, a paired Student’s t test was used, where *p < 0.05 and
**p < 0.005, and N indicates biological replicates (MSCs derived from different donors).cultured with or without FGF2 (Figure S2 and GEO reposi-
tory). A large-scale gene function analysis of the 246 tran-
scripts increased with FGF2 revealed a strong enrichment
for genes related to cell-cycle progression and proliferation
(Figure S2). Among the 267 downregulated transcripts,
collagen-related processes were highly represented. We
also confirmed several migration-related genes as regulated
by FGF2, including upregulation of DOCK4, PODXL, and
ITGA3 and downregulation of RHOB, ITGA11, and ITGAV
(Figure 1C). These results suggest that FGF2 promotes
migration ofMSCs through coordinated regulation of mul-
tiple genes.
We next investigated if FGF2 could also induce post-
translational changes that could account for increased
migration. A major modification in membrane-associated
proteins (MAPs) are N-glycans that occur in the ER and326 Stem Cell Reports j Vol. 11 j 325–333 j August 14, 2018Golgi apparatus. In fact, we found multiple glycosylation-
related genes differentially expressed with FGF2 (Fig-
ure S2B). Therefore, MSCs were treated with or without
FGF2 and processed for extraction ofMAPs and semi-quan-
titative analysis by mass spectrometry (MS) (Park et al.,
2015). We found a decrease in high-mannose N-glycans
and a mild trend to increase sialylations (Figure S1),
whereas the most consistent observation was an increase
in fucosylated N-glycans (Figure 1D). Most fucosylated
N-glycans (92.7%) showed one fucose, which is usually
attached to the first N-acetylglucosamine within the chito-
biose core and are therefore called core fucosylation.
Notably, the MS analysis was in accordance with
the RNA-seq data, because core fucosylations are
catalyzed by a-1,6-fucosyltransferase (FUT8) (Yang and
Wang, 2016), and FUT8 was significantly upregulated by
(legend on next page)
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FGF2 (Figure 1F). Hydrolysis of core fucosylations is cata-
lyzed by both a-L-fucosidase 1 (FUCA1) and FUCA2. Expres-
sion of FUCA2 was not affected by FGF2, while FUCA1 was
downregulated by FGF2, although this reduction (0.2-fold)
was not as pronounced as the increase in FUT8 (2.0-fold).
Since fibroblasts derived from FUT8/ mice show
impaired migration (Zhao et al., 2006), we tested if FUT8
would affect migration of human MSCs. Indeed, the
increasedmigration induced by FGF2 was strongly reduced
in MSCs transduced with a lentivirus to silence FUT8
(shFUT8; Figure 1E), suggesting that core fucosylations
are necessary for migration of MSCs.
We previously showed that FGF2 quickly increases High-
Mobility Group 2A (HMGA2) mRNA and protein levels in
MSCs (Kalomoiris et al., 2016). In addition to HMGA2,
we also found the homolog HMGA1 strongly increased by
FGF2 (Figure 1F). To test if the increase of FUT8 is regulated
byHMGA2, we transducedMSCswith either a control short
hairpin RNA (shControl) or a shRNA to silence HMGA2
(shHMGA2) and then incubated the cells with or without
FGF2. In MSCs transduced with shControl, FGF2 markedly
increased FUT8 protein expression. However, in MSCs
transduced with shHMGA2, FUT8 expression was very
low, even in the presence of FGF2, suggesting that
HMGA2 acts downstream of FGF2 to regulate FUT8 expres-
sion (Figure 1G). To determine potential transcription fac-
tors that could induce FUT8 expression, we found that
the FUT8 promoter shows multiple E2F binding sites,
including at least three for E2F1. Interestingly, E2F1 expres-
sionwas increasedwith FGF2 (Figure 1F), while others have
shown that HMGA2 increases E2F1 activity (Fedele et al.,
2006). Overall, these results suggest that FGF2 increases
core fucosylations through a signaling pathway involving
HMGA2, leading to transcriptional increase of FUT8.
Fucosylation of Integrins Are Essential for Migration
of MSCs
To determine which specific MAPs were core-fucosylated,
we used a liquid chromatography-tandem MS (LC-MS/Figure 2. Core Fucosylations on Integrins Regulate Migration of M
(A) Correlation analysis of membrane associated proteins mRNA (as det
MRM/MS (N = 2, each with and without FGF2). Integrin b1 is highligh
(B) Correlation analysis of integrins, **p = 0.0011, as determined us
(C) Number of N-glycans found in integrins expressed in MSCs. Dark sec
non-fucosylated N-glycans.
(D) Wound/scratch assay on uncoated plates of MSCs transduced twi
shControl or shFUT8. N = 6.
(E and G) Wound/scratch assays of MSCs cultured over different subs
(F and H) Videomicroscopy over 12 hr of MSCs cultured over different s
N = 30 cells, derived from three different donors.
Error bars indicate standard error of the mean (SEM). Statistical differe
t test (paired for D, E, and G and non-paired for F and H), where *p
replicates, except when otherwise indicated.
328 Stem Cell Reports j Vol. 11 j 325–333 j August 14, 2018MS)-based multiple reaction monitoring (MRM) approach
for glycoprotein analysis (Hong et al., 2013). We consis-
tently detected a total of 241 peptides corresponding
to 118 different MAPs, treated with or without FGF2
(Table S1). Most proteins showed 1–10 different types of
N-glycans (average 6.5; Figure 2A) and no correlation was
found between relative mRNA levels (determined by
RNA-seq) and number of types of N-glycans (measured by
MRM). However, among integrins, mRNA levels strongly
correlated with the variety of N-glycans found (Figure 2B).
Integrin b1 stands out for exhibiting on average 70 different
types of N-glycans, 56% of them fucosylated. Also, integrin
subunits a3, a5, a11, and aV showed fucosylated N-glycans,
although at low levels, as compared with b1 (Figure 2C).
These results show that various integrins, and especially
subunit b1, are core-fucosylated.
The role of core fucosylation on integrin b1 was
experimentally supported by a wound/scratch assay.
Here, silencing FUT8 shows the same inhibitory effect
as silencing integrin b1, while silencing both FUT8
and integrin b1, leads to no additional inhibition
(Figure 2D).
To further assess the functional effect of core fucosyla-
tions, we performed migration assays over different
extracellular matrix, known to be specific integrin li-
gands. Based on integrin’s expression levels and fucosyla-
tions, we used collagen I to assess a11b1, fibronectin to
assess a5b1 and aVb1, and laminin to assess for a3b1 activ-
ity. Using the wound/scratch assay and single-cell
tracking, we found that silencing FUT8 inhibited migra-
tion on all substrates (Figures 2D and 2E). In the
wound/scratch assay, over-expression of FUT8 increased
MSC migration over polystyrene (uncoated plates) and
laminin (Figure 2F), while over collagen and fibronectin,
MSCs virtually closed the wounds within 24 hr, hence no
additional increase in migration could be detected. How-
ever, in single-cell tracking assays, over-expression of
FUT8 increased migration of MSCs on all surfaces tested
(Figure 2G). These results suggest that core fucosylationsSCs
ermined by RNA-seq; N = 4) and number of N-glycans types found by
ted in red.
ing a Pearson correlation analysis.
tion of each column denotes fucosylated N-glycans, light section is
ce, with either shControl or shITGB1 (to silence integrin b1), and
trates; N = 6 for both experiments.
ubstrates, transduced to either silence (E) or over-express (G) FUT8.
nces were determined using two-way ANOVA with post hoc Student’s
< 0.05 and **p < 0.005. ***p < 105, and N indicates biological
Figure 3. Silencing FUT8 Affects Migration of MSC in Zebrafish and Mice
(A) Representative image of GFP-expressing human MSCs around the head of 1-dpf zebrafish. Insert shows high magnification, where
protrusions from an individual cell are visible.
(B) MSCs distributed around the trunk region.
(C) MSCs distributed in the tail. Distribution of transplanted cells is highlighted by arrows.
(D) Quantification of cell distribution, where *p < 0.05 as assessed using a paired Student’s t test (N = 5 independent experiments
performed with biological replicates).
(E) Seven days after bone fracture and intramuscular injection of cells, mice were analyzed for presence of tdTomato-expressing mouse
MSCs. Control cells distribute abundantly in callus and bone marrow of the fractured femur.
(F) MSCs with shFUT8 only minimally reach the new callus and bone marrow on fracture site.
Error bars indicate standard error of the mean (SEM). Scale bars, 100 mm.on integrin b1 are both necessary and sufficient to pro-
mote MSC migration.
FUT8 Is Necessary for Migration of MSCs In Vivo
Zebrafish embryos have been used as platforms for assaying
mammalian cancer cell behavior, as xenotransplanted cells
develop tumors and metastasize (Marques et al., 2009). The
transparency of embryos and absence of a functional innate
immune system until 2 days post fertilization (dpf), allow
imaging of fluorescently labeled transplanted cells over
time. To study the role of FUT8onmigrationofMSCs in vivo,
we introduced green or red fluorescently labeled MSCs into
wild-type zebrafish blastulae (4 hr postfertilization [hpf]).
One day after transplantation, control MSCs distributed
mostly in the anterior embryo (brain, eye, heart, gill arches)
and, to a lesser extent, in the trunk and tail (Figures 3A and
3B). In contrast, shFUT8 transduced MSCs accumulate
almost exclusively in the lateral trunk, often directly under
the skin (posterior to the hindbrain and anterior to the yolk
extension; Figure 3C), and they tended to clump together.
We quantified the position of MSCs along the anterior-pos-
terior axis and found a significant difference between con-
trol and FUT8 mRNA-depleted cells (Figure 3D).We recently showed that over-expression of FGF2 in
MSCs accelerates bone repair in mice, which we hypothe-
sized is driven by increased migration, since with FGF2,
more MSCs were found at the fracture site at early time
points (Zhang et al., 2017). We therefore tested if inhibi-
tion of FUT8 would alter the incorporation of MSCs into
the fractured femur. Immediately following a femoral frac-
ture in the right hindlimb, FGF2-treated cells (transduced
with either shControl or shFUT8) were injected into both
left and right thighs close to the fracture site. Cells were
then allowed to migrate toward the fracture site for
7 days. As previously reported (Zhang et al., 2017), only
a very few cells incorporated into the left, unfractured,
femur (not shown). On the fractured site, control MSCs
were abundantly found incorporated into the callus and
some cells were observed in the bone marrow. In contrast,
MSCs transduced with shFUT8 were barely detectable at
the fracture site. Since these cells were still present in the
muscle (around the injection site), we conclude that
shFUT8 did not affect cell retention, but rather inhibited
cell migration toward the fracture site. These results
further support that FUT8 is essential for migration of
MSCs in vivo.Stem Cell Reports j Vol. 11 j 325–333 j August 14, 2018 329
Figure 4. Molecular Modeling Suggests that Core Fucosylations Alter the Orientation of N-Glycans on Integrin b1
(A) Schematic view of N-glycan analyzed, depicting dihedral angles; colored insert shows a cartoon version, where blue squares are
N-acetylglucosamine, green circles are mannose, yellow circles are galactose, and red triangle is fucose.
(B) Extracellular domain of integrin b1 with N-glycan and fucosylated N-glycan. Amino acid Asp329 is highlighted; during modeling, the
fucosylated N-glycan often establishes hydrogen bonds with it.
(C) Torsion dihedral angles over simulation showing more restricted N-glycan orientation with core fucosylation.Core Fucosylation May Limit the Movement
of N-Glycans
To study how core fucosylations affect protein function, we
usedmolecular dynamics.We detected six glycosylated res-
idues on integrin b1, all in the extracellular domain, facing
the surface of the protein (Video S1). We performed mini-
mization and equilibration calculations to attach in silico
one glycan (Figure 4A) to Asn265 as actually found in our
MRM analysis in both forms, with andwithout core fucose.
After extensive equilibration, we performed simulations
and found that the fucosylated glycan shows more
restricted movement, as compared with the non-fucosy-
lated glycan (Videos S2 and S3). This was at least partially
due to hydrogen bonds built in-between the fucose and
Asn329 (Figure 4B). The restrictedmovements of the fucosy-
lated glycan were also noticeable in dihedral angles. Inter-
estingly, we found the strongest effects on the bond in-be-
tween the glycan and Asn265 (torsions of the acetamido330 Stem Cell Reports j Vol. 11 j 325–333 j August 14, 2018and hydroxymethyl groups) and on the a1,3 antenna (tor-
sion angles A and B) (Figure 4C). In contrast, dihedral an-
gles along the center portion (chitobiose core) of the glycan
and the a1,6 antenna were only minimally altered (Fig-
ure S4). Altogether, molecular dynamics suggest that core
fucosylations may reduce total glycan ensembles, possibly
favoring the interaction of the glycan with other
molecules.DISCUSSION
Our gain- and loss-of function experiments demonstrate
that FUT8 affects migration of MSCs. Core fucosylations
on N-glycans attached to integrin b1 seemed particularly
relevant, because integrin b1 showed over ten times more
types of N-glycans as compared with the average for
MAPs. Also, silencing integrin b1 or FUT8 inhibited
migration similarly, with no additive effect when silencing
both genes together. Of note, in fibroblasts, regulation of
integrins is associated with the different a subunits, while
b1 integrin is considered to be synthesized in excess (Heino
et al., 1989). We now propose that b1 integrin is primarily
regulated at the post-translational level. Integrin b1 is the
predominant adhesion receptor subfamily in human
MSCs (Gronthos et al., 2001), where ligand binding, dimer-
ization, or clustering (Guo et al., 2002) and interactionwith
tetraspanins (Goschnick et al., 2006) are all likely depen-
dent on changes on glycosylation.
Our study in mice with bone fracture further supports a
critical role of FUT8 on cell migration, but how reduced
migration affects the therapeutic effect of MSCs remains
unknown. Bone repair is assessed 3–8 weeks after fracture,
while we determined incorporation of cells into the frac-
ture 1 week after injection. Also, future work is necessary
to determine if pre-incubation with FGF2 or direct increase
of core fucosylations on integrin b1 can improve MSC
homing.
Xenotransplantation of human MSCs in zebrafish is a
promising tool to assess cell migration in vivo, even at the
single-cell level. Future work is necessary to understand
how in this model, cell migration is dictated, since it
possibly involves chemotaxis, adhesion, and cell motility.
Since core fucosylations associate with various types of
metastatic tumors (Geng et al., 2004; Taniguchi and Ki-
zuka, 2015;Wang et al., 2014), it will be important to deter-
mine if our findings are confirmed in other cell types,
including cancer cells.
In accordance with the mitogenic effect of FGF2 on
MSCs, we found that most of the upregulated genes
with FGF2 relate to cell-cycle progression and prolifera-
tion. Arguably, the wound/scratch assays with FGF2
could be biased by increased cell numbers. However, after
24 hr, MSCs treated with FGF2 are only 10% more than
control cells (not shown), indicating that most of the
wound closure is due to an effect on cell migration,
rather than proliferation. Similarly, we observed that
immediately after cell division, MSCs exert the highest
motility. We therefore avoided tracking cells that had un-
dergone recent (within 1 hr) cell division. Of note, FGF2
reduces cell adhesion to uncoated plates, a process that
was not affected by either silencing or over-expressing
FUT8 (not shown).
Many genes are regulated by both HMGA1 and HMGA2,
but some genes are specifically regulated by only one of
them (Federico et al., 2014). Since HMGA2 strongly in-
creases E2F1 activity (Fedele et al., 2006), but we found
both HMGA1 and HMGA2 increased by FGF2, it will be
important to test if also silencing HMGA1 could affect
FGF2 -mediated FUT8 expression. It will be also relevant
to verify the FGF2/HMGA2/FUT8 pathway in other typesof stem cells, because inmany of themHMGA2 is an essen-
tial regulator of self-renewal.
In addition to increased core fucosylations with FGF2, we
also found a decrease in high-mannose N-glycans. This is
consistent with the notion that high-mannose N-glycans
need to be first trimmed in the ERmembrane, prior to being
core-fucosylated in the late Golgi cisternae (Kornfeld and
Kornfeld, 1985). The role of most N-glycan modifications
in MSCs remains unknown and deserves future investiga-
tion. In addition to migration, N-glycans may affect recep-
tor function or the interaction with other cells and
substrates.
Finally, altering integrin function affects migration, but
also adhesion and survival, and can even define cell fate
under differentiation cues (Dalby et al., 2014). Although
technically challenging, changes in N-glycans of specific
proteins or even specific residues hold the potential to
modulate and alter protein function. Our results suggest
that FGF2 triggers transcriptional changes, which lead to
post-translational modifications, hence affecting cellular
migration in a highly complex, but coordinated way.EXPERIMENTAL PROCEDURES
Cell Culture
Human and mouse MSCs were isolated from bone marrow (Fierro
et al., 2011). Each experiment repetition (N) was performed with
MSCs derived from a different donor. All experiments with FGF2
use 24-hr incubation, 10 ng/mL FGF2.
In VitroMigration Assays
For the wound/scratch assay, MSCs were seeded into plates with
Cytoselect inserts. The next day, inserts were removed, leaving a
‘‘wound’’ (open area), and pictures were taken immediately and
24 hr after, unless otherwise described. For videomicroscopy, cell
displacement was recorded using in a BioStation microscope.
RNA-Seq
Total RNA from four different donors treated with or without FGF2
sequencing was performed in two SE50 lanes using the Hiseq2000
platform (Illumina).
Mass Spectrometry
For N-glycan analysis, cells were processed for NanoLC/ESI-
QTOF-MS, as previously described (Park et al., 2015). For LC-
MS/MS analysis, enriched glycopeptides were identified using a
Q Exactive Plus mass spectrometer.
Migration Assay toward Bone Fracture in Mice
Studies in mice were performed strictly following protocols
approved by the Institutional Animal Care and Use Committee
(IACUC) at UC Davis. Closed transverse diaphysis fractures of
the right femur were generated as previously described (Zhang
et al., 2017). Immediately after, mouse MSCs (transduced withStem Cell Reports j Vol. 11 j 325–333 j August 14, 2018 331
either shControl or shFUT8, and pre-incubated FGF2) were in-
jected intramuscularly (five mice per group), near the fracture
site. After 7 days, mice were euthanized and samples fixed and
embedded to visualize the injected cells based on tdTomato.Modeling Analysis
The crystal structure of b1 integrin was taken from the a5b1 integ-
rin headpiece in complex with an arginylglycylaspartic acid (RGD)
peptide (PDB ID: 3VI4) (Nagae et al., 2012). After minimization
and equilibration steps, four independent simulations of 70 ns
were collected. To compare glycans with or without core fucose,
torsion angles were collected from each simulation with a tempo-
ral resolution of 50 ps.Statistical Analysis
Results were presented as mean ± SEM. Depending on the number
of compared conditions, one-way ANOVA, two-way ANOVA, or
two-tailed Student’s t test were conducted using GraphPad Prism
Software; p values < 0.05 were considered statistically significant.ACCESSION NUMBERS
RNA-seq data are available at GEO under accession number: GEO:
GSE115240.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, one table, and three videos and can be
found with this article online at https://doi.org/10.1016/j.stemcr.
2018.06.007.
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